Result of AGM
CelLBxHealth plc announced that all resolutions were passed at its Annual General Meeting, with the exception of resolution 4, which was withdrawn due to the departure of Mr P M Collins from the business on July 6, 2026. Voting details are available on the company's investor relations website.
Select text to share a quote on X · sign in to keep highlights & notes in your CLBX notes
Guildford, UK and Plymouth Meeting, U.S. - 14 July 2026 - CelLBxHealth plc (AIM: CLBX), a CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, announces that at the Annual General Meeting of the Company held earlier today, with the exception of resolution 4 which has been withdrawn, all resolutions were duly passed. Resolution 4 was to re-appoint Mr P M Collins as a Director of the Company. Mr Collins left the business on 6 July 2026.
Details of the voting are available on the Investor Relations section of the Company's website: https://cellbxhealth.com/information-for-investors-cellbxhealth-plc/financial-reports/#general-meeting-documentation
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.